18124864. Biocomputing platform and Boolean logic gates simplified abstract (REGENTS OF THE UNIVERSITY OF MINNESOTA)

From WikiPatents
Revision as of 06:30, 1 October 2024 by Wikipatents (talk | contribs) (Creating a new page)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Biocomputing platform and Boolean logic gates

Organization Name

REGENTS OF THE UNIVERSITY OF MINNESOTA

Inventor(s)

Judee Sharon of Minneapolis MN (US)

Katarzyna Adamala of Minneapolis MN (US)

Aaron Engelhart of Minneapolis MN (US)

Biocomputing platform and Boolean logic gates - A simplified explanation of the abstract

This abstract first appeared for US patent application 18124864 titled 'Biocomputing platform and Boolean logic gates

The abstract describes a platform for biocomputing technology that utilizes DNA, enzymes, and transcriptional RNA aptamers to control biological reactions and produce RNA or protein products in a cell-free environment.

  • The platform includes a variety of logic gates for operation within the system.
  • The technology allows for the designing and verification of multiple Boolean logic gates.
  • DNA, enzymes, and transcriptional RNA aptamers are used to control one or more biological reactions.
  • The platform enables the formation of RNA or protein products through these controlled reactions.
  • The system provides a versatile tool for researchers working in the field of biocomputing technology.

Potential Applications: - Biomedical research - Drug development - Synthetic biology

Problems Solved: - Facilitates precise control over biological reactions - Enables the production of specific RNA or protein products - Enhances the efficiency of biocomputing technology

Benefits: - Increased accuracy in controlling biological processes - Accelerated research and development in various fields - Potential for innovative applications in biotechnology

Commercial Applications: Title: "Revolutionizing Biocomputing Technology: Commercial Opportunities and Market Impact" This technology could be utilized in industries such as pharmaceuticals, biotechnology, and research institutions to enhance their capabilities in designing and controlling biological systems.

Prior Art: Researchers interested in this technology may want to explore existing patents related to biocomputing, synthetic biology, and molecular biology to gain a better understanding of the field.

Frequently Updated Research: Stay updated on the latest advancements in biocomputing technology, synthetic biology, and molecular engineering to leverage the full potential of this innovative platform.

Questions about Biocomputing Technology: 1. How does this platform improve the efficiency of biological reactions compared to traditional methods? 2. What are the potential long-term implications of integrating logic gates into biocomputing technology?


Original Abstract Submitted

A platform for biocomputing technology including a plurality of logic gates for operation in a cell-free environment using DNA, enzymes, and transcriptional RNA aptamer outputs for controlling one or more biological reactions to form RNA or protein products and a platform for the designing and verifying of a plurality of Boolean logic gates.

Retrieved from "http://wikipatents.org/index.php?title=18124864._Biocomputing_platform_and_Boolean_logic_gates_simplified_abstract_(REGENTS_OF_THE_UNIVERSITY_OF_MINNESOTA)&oldid=245778"